Citations

Showing 10 of 108094 citations.

Complex electrophysiological remodeling in postinfarction ischemic heart failure
Hegyi, Bence , Bossuyt, Julie , Griffiths, Leigh G. , Shimkunas, Rafael, Coulibaly, Zana, Jian, Zhong , Grimsrud, Kristin, Søndergaard, Claus S., Ginsburg, Kenneth S., Chiamvimonvat, Nipavan , Belardinelli, Luiz, Varró, András , Papp, Julius Gy., Pollesello, Piero , Levijoki, Jouko , Izu, Leighton T. , Boyd, W. Douglas, Bers, Donald M. , Chen‐Izu, Ye , Griffiths, Leigh G , Bányász, Tamás

Mayo Clinic

Proceedings of the National Academy of Sciences | March 12, 2018 | Volume: 115 | Issue: 13 | Pages: No page available

10.1073/pnas.1718211115 | PMID 29531045 Get It

Significance Cardiac arrhythmias often occur in heart failure (HF) patients, but drug therapies using selective ion channel blockers have failed clinical trials and effective drug therapies remain elusive. Here we systematically study the major ionic currents during the cardiac action potential (AP) and arrhythmogenic Ca 2+ release in postinfarction HF. We found that changes in any individual current are relatively small, and alone could mislead as to consequences. However, differential changes in multiple currents integrate to shorten AP in the infarct border zone but prolong AP in the remote zone, increasing AP repolarization inhomogeneity. Our findings help explain why single channel-blocker therapy may fail, and highlight the need to understand the integrated changes of ionic currents in treating arrhythmias in HF.
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)
Chumsri, Saranya , Sperinde, Jeff, Liu, Heshan , Gligorov, Joseph , Spano, Jean-Philippe, Antoine, Martine , Aspitia, Alvaro Moreno, Tan, Winston , Winslow, John , Petropoulos, Christos J. , Chenna, Ahmed , Bates, Michael, Weidler, Jodi, Huang, Weidong , Dueck, Amylou C. , Perez, Edith A. , Moreno Aspitia, Alvaro, Dueck, A. C. , Gligorov, Joseph

Mayo Clinic

Clinical Cancer Research | March 12, 2018 | Volume: 24 | Issue: 13 | Pages: 3053-3058

10.1158/1078-0432.ccr-17-1864 | PMID 29530935 Get It

Abstract Purpose: p95HER2 is a truncated form of HER2 that confers resistance to trastuzumab in vitro, but clinical results have been conflicting to date. Given that p95HER2 levels correlate with total HER2 expression levels, which confer better outcomes, we sought to evaluate the p95HER2/HER2 ratio in the North Central Cancer Treatment Group N0337 and N98-32-52 trials. Experimental Design: The HERmark assay and VeraTag technology (Monogram Biosciences) were used to measure total HER2 and p95HER2 expression levels in 91 patient samples. Results: In the multivariate model, increasing total HER2 level was significantly associated with longer (OS; HR, 0.33; P = 0.002) and decreasing p95HER2 level was significantly associated with longer OS (HR, 4.2; P = 0.01). Total HER2 expression level was significantly associated with longer progression-free survival (PFS) (HR, 0.57; P = 0.04), whereas p95HER2 level was not (HR, 1.7; P = 0.25). However, there was a positive association between p95HER2 and total HER2 expression levels (R2 = 0.48; P < 0.001). Consistent with our hypothesis, the ratio of p95HER2/HER2 was significantly associated with worsening PFS (HR, 1.7; P = 0.04) and OS (HR, 2.8; P = 0.002). Patients with the highest tertile of p95HER2/HER2 values had significantly less favorable PFS (HR, 1.8; P = 0.06) and OS (HR, 2.3; P = 0.02). Conclusions: A high p95HER2/HER2 ratio identified patients with metastatic breast cancer with poor outcomes on trastuzumab-based therapies. Further investigation of the p95HER2/HER2 ratio as a potential prognostic or predictive biomarker for HER2-targeted therapy is warranted. Clin Cancer Res; 24(13); 3053–8. ©2018 AACR.
Take care to identify apathy in idiopathic rapid eye movement sleep behavior disorder
Louis, Erik K. St. , St Louis, E K

Mayo Clinic

European Journal of Neurology | March 12, 2018 | Volume: 25 | Issue: 7 | Pages: 903-904

10.1111/ene.13627 | PMID 29528541 Get It

High Tibial Osteotomy Performed With All-PEEK Implants Demonstrates Similar Outcomes but Less Hardware Removal at Minimum 2-Year Follow-up Compared With Metal Plates
Momaya, Amit , Adams, Kyle J. , Long, Catherine D., Tokish, John M. , Wyland, Douglas J., Roberson, Tara M.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | March 12, 2018 | Volume: 6 | Issue: 3 | Pages: No page available

10.1177/2325967117749584 | PMID 29560369 Get It

Background: High tibial osteotomy (HTO) is a valuable treatment option in the high-demand patient with chondral damage and an altered mechanical axis. Traditional opening wedge HTO performed with metal plates has several limitations, including hardware irritation, obscuration of detail on magnetic resonance imaging, and complexity of revision surgery. Recently, an all-polyetheretherketone (PEEK) HTO implant was introduced, but no studies to date have evaluated the performance of this implant with minimum 2-year outcomes compared with a traditional metal plate. Purpose: To compare patient outcomes and complications of HTO performed using a traditional metal plate with those performed using an all-PEEK implant. Study Design: Cohort study; Level of evidence, 3. Methods: All patients who underwent HTO by a single surgeon with a minimum 2-year follow-up over a 4-year period were identified. Medical records were reviewed for patient demographics, concomitant procedures, implant used, type and degree of correction, complications, reoperations, and failures. Recorded patient outcomes included EuroQol–5 dimensions (EQ-5D), resiliency, Single Assessment Numeric Evaluation (SANE), Tegner activity level scale, International Knee Documentation Committee (IKDC), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores. HTO performed using a traditional metal plate served as the control group. Statistical analysis was performed using the Student t test for continuous variables and chi-square analysis for nonparametric data, with P < .05 considered significant. Results: A total of 41 patients (21 in the all-PEEK group, 20 in the control group) were identified with greater than 2-year follow-up. The mean patient age was 44 years, and there were no differences between the groups with regard to demographics, degree of correction, or concomitant procedures. In addition, no significant differences were found for any of the patient-reported outcomes. Complications (10% vs 15%, respectively; P = .59), failures (10% vs 5%, respectively; P = .58), and reoperations (10% vs 30%, respectively; P = .10) were similar for the all-PEEK and control groups. However, the all-PEEK group did not have any hardware removal, while 4 patients in the control group underwent hardware removal ( P = .03). Conclusion: This study suggests that an all-PEEK implant may be safely used with comparable outcomes and complication rates to the traditional method but with less need for hardware removal.
Oncolytic Adenoviruses in Gastrointestinal Cancers
Yokoda, Raquel T. , Nagalo, Bolni Marius , Nagalo, Bolni M, Nagalo, Bolni , Borad, Mitesh J. , Yokoda, Raquel T

Mayo Clinic

Biomedicines | March 12, 2018 | Volume: 6 | Issue: 1 | Pages: 33

10.3390/biomedicines6010033 | PMID 29534501 Get It

Gastrointestinal malignancies are challenging cancers with considerable economic and societal impacts on health care systems worldwide. While advances in surgical approaches have provided benefits to a proportion of patients, only modest improvements have been attained in the treatment of patients with advanced disease, resulting in limited improvement in survival rates in these patients. Oncolytic adenoviruses are being developed to address gastrointestinal malignancies. Each platform has evolved to maximize tumor-cell killing potency while minimizing toxicities. Tumor-specific bioengineered adenoviruses using chimeric promoters, prodrug convertase enzymes, lethal genes, tumor suppressor genes, and pseudo-typed capsids can provide the innovations for eventual success of oncolytic virotherapy. This article will review the developments in adenoviral platforms in the context of specific gastrointestinal cancers. From the bench to the implementation of clinical trials, this review aims to highlight advances in the field from its early days to the current state of affairs as it pertains to the application of adenoviral oncolytic therapy to gastrointestinal cancers.
Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives
Shih, Robert , Koeller, Kelly K. , Shih, Robert Y, Shih, Robert Y

Mayo Clinic

RadioGraphics | March 12, 2018 | Volume: 38 | Issue: 2 | Pages: 525-541

10.1148/rg.2018170182 | PMID 29528832 Get It

Bariatric Surgery and Kidney Health
Lieske, John C.

Mayo Clinic

Journal of the American Society of Nephrology | March 12, 2018 | Volume: 29 | Issue: 4 | Pages: 1085-1086

10.1681/asn.2018020176 | PMID 29531098 Get It

Obesity, sedentary lifestyle, and video games: The new thrombophilia cocktail in adolescents
Kohorst, Mira A. , Rao, Amulya A. Nageswara , Rodriguez, Vilmarie , Warad, Deepti M, Warad, Deepti

Mayo Clinic

Pediatric Blood & Cancer | March 12, 2018 | Volume: 65 | Issue: 7 | Pages: No page available

10.1002/pbc.27041 | PMID 29528184 Get It

Abstract Rates of venous thromboembolism have increased in the adolescent population over the last two decades, likely due to advanced diagnostics, increased use of central venous catheters, chronic medical conditions, obesity, and oral contraceptive use. Of these factors, a modifiable risk factor for adolescents is obesity. Sedentary lifestyle and prolonged immobilization are additional prothrombotic risk factors that are often associated with obesity. With ever‐increasing screen time, sedentary behavior has risen accordingly, especially among gamers. We present four cases of adolescents who developed life‐threatening venous thromboembolic events in the setting of obesity, sedentary lifestyle and/or immobilization, and prolonged video game use.
Racial disparities in bipolar disorder treatment and research: a call to action
Akinhanmi, Margaret, Strakowski, Stephen M. , Berry, Joyce E Balls, Merikangas, Kathleen R. , McInnis, Melvin G. , Leboyer, Marion , Tamminga, C.A., Frye, Mark A. , Akinhanmi, Margaret O, Balls Berry, Joyce E, Merikangas, Kathleen , Biernacka, Joanna M. , McElroy, Susan L. , Assari, Shervin , Schulze, Thomas , Patten, Christi A. , Leboyer, Marion , McInnis, Melvin G

Mayo Clinic

Bipolar Disorders | March 12, 2018 | Volume: 20 | Issue: 6 | Pages: 506-514

10.1111/bdi.12638 | PMID 29527766 Get It

Objectives Health disparities between individuals of African and European ancestry are well documented. The disparities in bipolar disorder may be driven by racial bias superimposed on established factors contributing to misdiagnosis, including: evolving empirically based diagnostic criteria (International Classification of Diseases [ ICD ], Research Diagnostic Criteria [ RDC ] and Diagnostic and Statistical Manual [ DSM ]), multiple symptom domains (i.e. mania, depression and psychosis), and multimodal medical and additional psychiatric comorbidity. Methods For this paper, we reviewed the phenomenological differences between bipolar individuals of African and European ancestry in the context of diagnostic criteria and clinical factors that may contribute to a potential racial bias. Results Published data show that bipolar persons of African ancestry, compared with bipolar persons of non‐African ancestry, are more often misdiagnosed with a disease other than bipolar disorder (i.e. schizophrenia). Additionally, studies show that there are disparities in recruiting patients of African ancestry to participate in important genomic studies. This gap in biological research in this underrepresented minority may represent a missed opportunity to address potential racial differences in the risk and course of bipolar illness. Conclusion A concerted effort by the research community to increase inclusion of diverse persons in studies of bipolar disorder through community engagement may facilitate fully addressing these diagnostic and treatment disparities in bipolar individuals of African ancestry.
Endovascular Occlusion of Epidural Spinal Dural Arteriovenous Fistula: 2-Dimensional Operative Video
Sorenson, Thomas J. , Zaed, Ismail , Rangel-Castilla, Leonardo , Rangel-Castilla, Leonardo , Lanzino, Giuseppe

Mayo Clinic

Operative Neurosurgery | March 12, 2018 | Volume: 15 | Issue: 6 | Pages: 726-726

10.1093/ons/opy031 | PMID 29538711 Get It